# Albumin

## Alburx inj 20% 50mL

| TAH Drug Code      | [IALBU20](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IALBU20)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypoproteinemia， shock， burns.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Usual dose: IV 25 g; initial dose may be repeated in 15-30 minutes if response is inadequate. Adults: Hypovolemia: IV Initial 12.5-25 g (250-500 mL); repeat after 15-30 minutes as needed (if hemodynamic stability is not achieved). Cirrhotic ascites， therapeutic large volume paracentesis (adjunctive agent): IV 6-8 g for every liter removed or 50 g total for paracentesis >5 L. Ovarian hyperstimulation syndrome (treatment): IV 50-100 g over 4 hours; repeat at 4-12 hours intervals as needed. Infants， Children， and Adolescents: Ascites with hypoalbuminemia: Limited data available: IV 0.5-1 g/kg/dose over 2-3 hours; may repeat up to 3 times per day until albumin is >2.5 g/dL; maximum dose: 25 g/dose. Hypovolemia， plasma volume expansion， including hypovolemic shock: IV 0.5-1 g/kg/dose (10-20 mL/kg/dose) over 5-10 minutes. Note: Usual adult dose: 12.5-25 g/dose (250-500 mL/dose). May repeat after 15-30 minutes if response is not adequate. Large volume paracentesis: Limited data available: IV 0.5-1 g/kg over 1-2 hours after paracentesis. Nephrotic syndrome edema， refractory: IV 0.5-1 g/kg/dose over 30-60 minutes followed by diuretic therapy. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | History of hypersensitivity reaction to albumin preparations or to any component of the product (eg， N-acetyltryptophan， sodium caprylate). Patients with severe anemia or cardiac failure with normal or increased intravascular volume. Patients at risk for circulatory overload (eg， history of congestive cardiac failure， renal insufficiency， or stabilized chronic anemia).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Frequency not defined: flushing， heart failure， hypotension， tachycardia， pruritus， skin rash， urticaria， nausea， vomiting， chills， rigors， bronchospasm， dyspnea， pulmonary edema， fever. Postmarketing: acute myocardial infarction， atrial fibrillation， hyperchloremic metabolic acidosis， dysgeusia， sialorrhea， anaphylactic shock， anaphylaxis， hypersensitivity reaction (including severe hypersensitivity reaction)， nonimmune anaphylaxis， type 1 hypersensitivity reaction， headache， febrile reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/albumin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

